Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

How Are We Going to Discover New Cancer Biomarkers? A Proteomic Approach for Bladder Cancer

22 Apr 2004

Abstract excerpt

A handful of cancer biomarkers are currently used routinely for population screening, disease diagnosis, prognosis, monitoring of therapy, and prediction of therapeutic response. Unfortunately, most of these biomarkers suffer from low sensitivity, specificity, and predictive value, particularly when applied to rare diseases in population screening programs. Thus, for the classic cancer biomarkers much is left to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Proteomics Techniques and Applications
Share to Ferroptosis and cancer prognosis
Share to Peptidase Inhibition and Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 15105344
DOI: 10.1373/clinchem.2004.032177

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

How Are We Going to Discover New Cancer Biomarkers? A Proteomic Approach for Bladder CancerPMID 15105344Read ↗

Proteomics and genomics of urinary bladder cancer.Semantic proximity Read ↗

Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?Semantic proximity Read ↗

Unmasking molecular profiles of bladder cancer.Semantic proximity Read ↗

Proteomics as a Complementary Technique to Characterize Bladder CancerSemantic proximity Read ↗

Molecular pathogenesis of urothelial carcinoma: the clinical utility of emerging new biomarkers and future molecular classification of bladder cancer.Semantic proximity Read ↗

Biomarkers in bladder cancerSemantic proximity Read ↗

Trends in urine biomarker discovery for urothelial bladder cancer: DNA, RNA, or protein?Semantic proximity Read ↗

Molecular biomarkers in urothelial bladder cancerSemantic proximity Read ↗

Molecular markers in bladder cancer: Novel research frontiersSemantic proximity Read ↗

Molecular markers for detection, surveillance and prognostication of bladder cancer.Semantic proximity Read ↗

Potential new urinary markers in the early detection of bladder cancerSemantic proximity Read ↗

Gene-based urinary biomarkers for bladder cancer: an unfulfilled promise?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.